Connection

Marina Davoli to Biosimilar Pharmaceuticals

Back to Details
This is a "connection" page, showing publications Marina Davoli has written about Biosimilar Pharmaceuticals.
Marina Davoli
Connection Strength
0.665
Biosimilar Pharmaceuticals
  1. Comparative efficacy and safety in ESA biosimilars vs. originators in adults with chronic kidney disease: a systematic review and meta-analysis. J Nephrol. 2018 06; 31(3):321-332.
    View in: PubMed
    Score: 0.534
  2. Comparative effectiveness and safety of erythropoiesis-stimulating agents (biosimilars vs originators) in clinical practice: a population-based cohort study in Italy. BMJ Open. 2017 03 10; 7(3):e011637.
    View in: PubMed
    Score: 0.131
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.